Indivior Pharmaceuticals Inc
INDV
Classement en actions
#4006
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Prix de l'action
$32.56
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$4.06B
Changement (1 jour)
-3.15%
Changement (1 an)
33.01%
Pays
US
Échange Indivior Pharmaceuticals Inc (INDV)
Catégorie
Healthcare
EPS pour Indivior Pharmaceuticals Inc (INDV)
EPS au June 2026 TTM : $2.84
Selon les derniers rapports financiers et le cours de l'action de Indivior Pharmaceuticals Inc, l’EPS actuel de la société (TTM) est de $2.84. À la fin de 2023, la société avait un EPS de $0.01 une augmentation par rapport à celui de 2022, qui était de $-0.37.
Historique de l'EPS de Indivior Pharmaceuticals Inc de 2016 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
